Ronald Andrews
2022
In 2022, Ronald Andrews earned a total compensation of $2.4M as Former President and Chief Executive Officer at Oncocyte Corp, a 19% decrease compared to previous year.
Compensation breakdown
| Option Awards | $745,933 |
|---|---|
| Salary | $459,692 |
| Stock Awards | $493,125 |
| Other | $653,845 |
| Total | $2,352,595 |
Andrews received $745.9K in option awards, accounting for 32% of the total pay in 2022.
Andrews also received $459.7K in salary, $493.1K in stock awards and $653.8K in other compensation.
Rankings
In 2022, Ronald Andrews' compensation ranked 1,537th out of 5,683 executives tracked by ExecPay. In other words, Andrews earned more than 73.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,537 out of 5,683 | 73rd |
Division Manufacturing | 777 out of 3,091 | 75th |
Major group Chemicals And Allied Products | 305 out of 1,406 | 78th |
Industry group Drugs | 283 out of 1,307 | 78th |
Industry In Vitro and In Vivo Diagnostic Substances | 4 out of 29 | 86th |
Source: SEC filing on May 19, 2023.
Andrews' colleagues
We found five more compensation records of executives who worked with Ronald Andrews at Oncocyte Corp in 2022.
2022
Gisela Paulsen
Oncocyte Corp
Chief Operating Officer
2022
Douglas Ross
Oncocyte Corp
Chief Scientific Officer
2022
Anish John
Oncocyte Corp
Chief Financial Officer
2022
Joshua Riggs
Oncocyte Corp
Chief Executive Officer
2022
James Liu
Oncocyte Corp